about
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoA novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxideZinc sparks are triggered by fertilization and facilitate cell cycle resumption in mammalian eggs.Biological evaluation of pH-responsive polymer-caged nanobins for breast cancer therapyThe many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetUrokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.Anatomic and radiologic review of chronic mesenteric ischemia and its treatment.Enantioselective reduction of ketones and imines catalyzed by (CN-box)Re(V)-oxo complexes.Size control of arsenic trioxide nanocrystals grown in nanowells.MDCT of chest, abdomen, and pelvis using attenuation-based automated tube voltage selection in combination with iterative reconstruction: an intrapatient study of radiation dose and image quality.Enantioselective reduction of imines catalyzed by a rhenium(V)-oxo complex.Spectral detector CT-derived virtual non-contrast images: comparison of attenuation values with unenhanced CT.
P50
Q28488457-2AE8AB2A-43D2-4FD4-AE4F-6DF91DA4C1C4Q34145056-33B0B4B9-7DA5-46EA-A18E-5DE754FBD128Q34609485-7D01D5B2-50F1-4584-AAC0-AC7568F62750Q35208509-9404CEB2-A313-44FA-98BE-F19E6D4E99B1Q36831957-C115DC8C-0502-4AB4-BFCE-77CD78D96746Q36997621-61AA996F-B652-42FA-97C4-47BE0F659DF1Q37451733-D735ADB4-6538-484C-8315-2406FD324B20Q38846054-21F8F116-931B-4080-88C3-70EADF32521CQ41978848-CEE3C24A-82B4-4FAE-86A1-EFCCAE6AA2B8Q42725724-BDFF88E7-7C71-4A17-90DF-D350F8DFA178Q44451719-6B3D7E68-2871-4493-B330-D763B1C437CDQ46349767-18FC871C-292F-4AEC-A825-D4626090F55DQ48049854-44F081ED-82C6-4B1C-9613-8F81CB67C3A9
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6728-0009
@en
name
Richard W Ahn
@ast
Richard W Ahn
@en
Richard W Ahn
@nl
type
label
Richard W Ahn
@ast
Richard W Ahn
@en
Richard W Ahn
@nl
prefLabel
Richard W Ahn
@ast
Richard W Ahn
@en
Richard W Ahn
@nl
P106
P31
P496
0000-0001-6728-0009